These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 8256209

  • 1. Thyroid-stimulating hormone activates phospholipase C in normal and neoplastic thyroid tissue.
    Shaver JK, Tezelman S, Siperstein AE, Duh QY, Clark OH.
    Surgery; 1993 Dec; 114(6):1064-9. PubMed ID: 8256209
    [Abstract] [Full Text] [Related]

  • 2. Increased phospholipase C activity in neoplastic thyroid membrane.
    Kobayashi K, Shaver JK, Liang W, Siperstein AE, Duh QY, Clark OH.
    Thyroid; 1993 Dec; 3(1):25-9. PubMed ID: 8388752
    [Abstract] [Full Text] [Related]

  • 3. Suppression of thyrotropin receptor-G protein-phospholipase C coupling by activation of protein kinase C in thyroid carcinoma cells.
    Broecker M, Mayr GW, Derwahl M.
    Endocrinology; 1997 Sep; 138(9):3787-96. PubMed ID: 9275066
    [Abstract] [Full Text] [Related]

  • 4. Stimulatory effect of vasoactive intestinal polypeptide on human normal and neoplastic thyroid tissue.
    Siperstein AE, Miller RA, Clark OH.
    Surgery; 1988 Dec; 104(6):985-91. PubMed ID: 2848326
    [Abstract] [Full Text] [Related]

  • 5. Thyrotropin regulation of adenylate cyclase activity in human thyroid neoplasms.
    Clark OH, Gerend PL.
    Surgery; 1985 May; 97(5):539-46. PubMed ID: 2986305
    [Abstract] [Full Text] [Related]

  • 6. Effect of somatostatin on adenylate cyclase activity in normal and neoplastic thyroid tissue.
    Siperstein AE, Levin KE, Gum ET, Clark OH.
    World J Surg; 1992 May; 16(4):555-60; discussion 560-1. PubMed ID: 1357826
    [Abstract] [Full Text] [Related]

  • 7. Unlike thyrotropin, thyroid-stimulating antibodies do not activate phospholipase C in human thyroid slices.
    Laurent E, Van Sande J, Ludgate M, Corvilain B, Rocmans P, Dumont JE, Mockel J.
    J Clin Invest; 1991 May; 87(5):1634-42. PubMed ID: 1673689
    [Abstract] [Full Text] [Related]

  • 8. Dissociation of thyrotropin-dependent enzyme activities, reduced iodide transport, and preserved iodide organification in nonfunctioning thyroid adenoma and multinodular goiter.
    Masini-Repiso AM, Cabanillas AM, Bonaterra M, Coleoni AH.
    J Clin Endocrinol Metab; 1994 Jul; 79(1):39-44. PubMed ID: 8027249
    [Abstract] [Full Text] [Related]

  • 9. Thyrotropin receptor-adenylate cyclase function in human thyroid neoplasms.
    Saltiel AR, Powel-Jones CH, Thomas CG, Nayfeh SN.
    Cancer Res; 1981 Jun; 41(6):2360-5. PubMed ID: 6263464
    [Abstract] [Full Text] [Related]

  • 10. Thyrotropin binding and adenylate cyclase activation in normal and neoplastic human thyroid tissue: lack of effect of thyroglobulin.
    Clark OH, Gerend PL, Nissenson RA.
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1157-63. PubMed ID: 7076796
    [Abstract] [Full Text] [Related]

  • 11. TSH binding correlates with TSH-stimulated thyroid adenylate cyclase activity in human thyroid tissues.
    Duh QY, Siperstein AE, Miller RA, Smeds S, Clark OH.
    Surgery; 1989 Dec; 106(6):967-73; discussion 973-4. PubMed ID: 2588124
    [Abstract] [Full Text] [Related]

  • 12. Heterologous desensitization in neoplastic thyroid cells: influence of the phospholipase C signal transduction system on the thyrotropin-adenylate cyclase signal transduction system.
    Tezelman S, Hoelting T, Jossart GH, Wong MG, Siperstein AE, Duh QY, Clark OH.
    World J Surg; 1998 Jun; 22(6):544-51. PubMed ID: 9597926
    [Abstract] [Full Text] [Related]

  • 13. Characterization of the thyrotropin receptor-adenylate cyclase system in neoplastic human thyroid tissue.
    Clark OH, Gerend PL, Goretzki P, Nissenson RA.
    J Clin Endocrinol Metab; 1983 Jul; 57(1):140-7. PubMed ID: 6304132
    [Abstract] [Full Text] [Related]

  • 14. Thyrotropin receptor-adenylate cyclase system in Hurthle cell neoplasms.
    Clark OH, Gerend PL.
    J Clin Endocrinol Metab; 1985 Oct; 61(4):773-8. PubMed ID: 2993348
    [Abstract] [Full Text] [Related]

  • 15. Thyrotropin (TSH) receptor and adenylate cyclase activity in human thyroid tumors: absence of high affinity receptor and loss of TSH responsiveness in undifferentiated thyroid carcinoma.
    Abe Y, Ichikawa Y, Muraki T, Ito K, Homma M.
    J Clin Endocrinol Metab; 1981 Jan; 52(1):23-8. PubMed ID: 6256403
    [Abstract] [Full Text] [Related]

  • 16. Thyrotropin does not activate the phosphatidylinositol bisphosphate hydrolyzing phospholipase C in the dog thyroid.
    Mockel J, Laurent E, Lejeune C, Dumont JE.
    Mol Cell Endocrinol; 1991 Dec; 82(2-3):221-7. PubMed ID: 1665452
    [Abstract] [Full Text] [Related]

  • 17. Increased cyclic adenosine 3',5'-monophosphate inhibits G protein-coupled activation of phospholipase C in rat FRTL-5 thyroid cells.
    Laglia G, Zeiger MA, Leipricht A, Caturegli P, Levine MA, Kohn LD, Saji M.
    Endocrinology; 1996 Aug; 137(8):3170-6. PubMed ID: 8754735
    [Abstract] [Full Text] [Related]

  • 18. The adenylate cyclase-cyclic AMP-phosphodiesterase system in pathological human thyroid.
    Macchia V, Mandato E, Carella C, Pisano G, Biscaglia G.
    J Endocrinol Invest; 1978 Oct; 1(4):337-45. PubMed ID: 229151
    [Abstract] [Full Text] [Related]

  • 19. Thyrotropin binding and adenylate cyclase stimulation in thyroid neoplasms.
    Clark OH, Gerend PL, Cote TC, Nissenson RA.
    Surgery; 1981 Aug; 90(2):252-61. PubMed ID: 6266060
    [Abstract] [Full Text] [Related]

  • 20. Constitutive activation of the Gs alpha protein-adenylate cyclase pathway may not be sufficient to generate toxic thyroid adenomas.
    Derwahl M, Hamacher C, Russo D, Broecker M, Manole D, Schatz H, Kopp P, Filetti S.
    J Clin Endocrinol Metab; 1996 May; 81(5):1898-904. PubMed ID: 8626855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.